Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Neuro-ophthalmology September 2024

Pharmacological Activation and Transgenic Overexpression of SIRT1 Attenuate Traumatic Optic Neuropathy Induced by Blunt Head Impact

PDF

Alex Kwok; Brahim Chaqour; Reas S. Khan; Puya Aravand; Kimberly Dine; Ahmara G. Ross; Kenneth S. Shindler
TAGS: mice, traumatic brain injuries, protein overexpression, optic nerve injuries, attenuation, pharmacology, vision
Trans. Vis. Sci. Tech.. 2024; 13(9):27. https://doi.org/10.1167/tvst.13.9.27

Glaucoma August 2024

Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma

PDF

Nuala O'Neill; Miranda Meng; Brahim Chaqour; Kimberly Dine; Neha Sarabu; Jennifer C. Pham; Kenneth S. Shindler; Ahmara G. Ross
TAGS: glaucoma, mice, spatial vectors, enhancer of transcription, genes, cytomegalovirus
Trans. Vis. Sci. Tech.. 2024; 13(8):37. https://doi.org/10.1167/tvst.13.8.37

ARVO Annual Meeting Abstract June 2024

SIRT1-Based Gene Therapy Targets a Gene Program Involved in Mitochondrial Turnover in Experimental Autoimmune Encephalomyelitis

Brahim Chaqour; Kimberly Dine; Ahmara Gibbons Ross; Kenneth S Shindler

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):420.

ARVO Annual Meeting Abstract June 2024

Comparing the Reliability of Manual Retinal Ganglion Cell Counting using Brn3a and RBPMS Labeling

Miranda Meng; Brahim Chaqour; Kimberly Dine; Jipeng Yue; Gui-Shuang Ying; Kenneth S Shindler; Ahmara Gibbons Ross

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2454.

Glaucoma April 2024

Comparison of Brn3a and RBPMS Labeling to Assess Retinal Ganglion Cell Loss During Aging and in a Model of Optic Neuropathy

PDF

Miranda Meng; Brahim Chaqour; Nuala O'Neill; Kimberly Dine; Neha Sarabu; Gui-Shuang Ying; Kenneth S. Shindler; Ahmara G. Ross
TAGS: aging, optic nerve disorders, reliability, retinal ganglion cells, mice
Invest. Ophthalmol. Vis. Sci.. 2024; 65(4):19. https://doi.org/10.1167/iovs.65.4.19

ARVO Annual Meeting Abstract June 2023

Evaluating the reliability of Brn3a and RBPMS as markers of retinal ganglion cells with age and ocular hypertension-induced disease

Miranda Meng; Kimberly Dine; Brahim Chaqour; Kenneth S Shindler; Jipeng Yue; Ahmara Gibbons Ross

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5461.

ARVO Annual Meeting Abstract June 2023

SIRT1 Protects Against Oxidative Stress in Human iPSC-RGCs

David Camacho; Brahim Chaqour; Thu T. Duong; Ahmara Gibbons Ross; Kenneth S Shindler

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):796.

ARVO Annual Meeting Abstract June 2023

AAV-mediated selective expression of the SIRT1 gene modulates a gene program of inflammation and retinal ganglion cell survival

Brahim Chaqour; Miranda Meng; David Camacho; Kimberly Dine; Kenneth S Shindler; Ahmara Gibbons Ross

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):794.

ARVO Annual Meeting Abstract June 2022

CCN2 regulates the extracellular matrix and facilitates retinal ganglion cell maturation in the developing retina

Charles Karrasch; Sohyun Moon; Golam Mohiuddin; Oleg Evgrafov; Brahim Chaqour

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4279.

ARVO Annual Meeting Abstract June 2021

The matricellular protein CCN2/CTGF is an extrinsic cue essential for retinal progenitor cell growth and diversification

Brahim Chaqour; Anastasiia Bulakhova; Golam Mohiuddin; Sangmi Lee

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2590.

ARVO Annual Meeting Abstract June 2021

Elucidating the role of EPOR signaling in an experimental model of neovascular age-related macular degeneration

Aniket Ramshekar; Eric Kunz; Colin Andrew Bretz; Brahim Chaqour; Mary Elizabeth Hartnett

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):633.

ARVO Annual Meeting Abstract June 2020

Connective tissue growth factor deletion induces retinal vascular defects and barrier dysfunction through yes-associated protein-dependent mechanisms

Brahim Chaqour; Sangmi Lee; Joseph Sinon; Andrew Leask; Golam Mohiuddin; Sohyun Moon

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5407.

ARVO Annual Meeting Abstract July 2019

The CCN1-YAP regulatory pathway is a novel angiomodulatory circuit that controls vascular growth and expansion in the retina

Brahim Chaqour; Maria B Grant; Sohyun Moon; Michele Luu; Sangmi Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1628.

ARVO Annual Meeting Abstract September 2016

Vascular Dysfunction in Per2 m/m mice is Mediated via the Upregulation Of Connective Tissue Growth Factor

Maria B Grant; Vaishnavi Jadhav; Jude Al-Sabah; Brahim Chaqour; Ashay D Bhatwadekar

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2716.

ARVO Annual Meeting Abstract September 2016

The matricellular protein CCN1 defines mural cell coverage and integrity of retinal vessels and reduces their susceptibility to pathological neovascular growth through the Wnt pathway

Brahim Chaqour; Maria B Grant; Menna Elaskandrany; Sangmi Lee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4530.

ARVO Annual Meeting Abstract June 2015

MicroRNA-155-dependent regulation of the matricellular protein CCN1 modulates neovascular growth in the retina

Brahim Chaqour; Maria B Grant; Lulu Yan; Sangmi Lee

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):42.

ARVO Annual Meeting Abstract June 2015

Type-2 Diabetes Alters the microRNA Expression Profiles of Progenitor Cell Populations

Lulu Yan; Hemabindu Chintala; Ashay D Bhatwadekar; Sugata Hazra; Maria B Grant; Brahim Chaqour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4675.

ARVO Annual Meeting Abstract June 2015

Circulating MicroRNA ( miRNA) Expression Signatures in Type 1 diabetic (T1D) Individuals Protected from Development of Diabetic Retinopathy (DR)

Maria B Grant; David Kent; Robert N Mames; Ashay D Bhatwadekar; L Yan; H Chintala; Brahim Chaqour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):48.

ARVO Annual Meeting Abstract April 2014

Control of physiological and pathological angiogenesis in the retina by the matricellular protein CCN1

Brahim Chaqour; Maria Grant; Jinog Choi; Izabella Krupska; Lulu Yan; Hemabindu Chintala

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3556.

ARVO Annual Meeting Abstract June 2013

The Matricellular Protein CCN1 is Required for Growth, Maturation and Stabilization of the Retinal Vasculature

Chintala Hemabindu; Jin-ok Choi; Jincai Shan; Maria Grant; Brahim Chaqour

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5141.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Pharmacological Activation and Transgenic Overexpression of SIRT1 Attenuate Traumatic Optic Neuropathy Induced by Blunt Head Impact

Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma

SIRT1-Based Gene Therapy Targets a Gene Program Involved in Mitochondrial Turnover in Experimental Autoimmune Encephalomyelitis

Comparing the Reliability of Manual Retinal Ganglion Cell Counting using Brn3a and RBPMS Labeling

Comparison of Brn3a and RBPMS Labeling to Assess Retinal Ganglion Cell Loss During Aging and in a Model of Optic Neuropathy

Evaluating the reliability of Brn3a and RBPMS as markers of retinal ganglion cells with age and ocular hypertension-induced disease

SIRT1 Protects Against Oxidative Stress in Human iPSC-RGCs

AAV-mediated selective expression of the SIRT1 gene modulates a gene program of inflammation and retinal ganglion cell survival

CCN2 regulates the extracellular matrix and facilitates retinal ganglion cell maturation in the developing retina

The matricellular protein CCN2/CTGF is an extrinsic cue essential for retinal progenitor cell growth and diversification

Elucidating the role of EPOR signaling in an experimental model of neovascular age-related macular degeneration

Connective tissue growth factor deletion induces retinal vascular defects and barrier dysfunction through yes-associated protein-dependent mechanisms

The CCN1-YAP regulatory pathway is a novel angiomodulatory circuit that controls vascular growth and expansion in the retina

Vascular Dysfunction in Per2 m/m mice is Mediated via the Upregulation Of Connective Tissue Growth Factor

The matricellular protein CCN1 defines mural cell coverage and integrity of retinal vessels and reduces their susceptibility to pathological neovascular growth through the Wnt pathway

MicroRNA-155-dependent regulation of the matricellular protein CCN1 modulates neovascular growth in the retina

Type-2 Diabetes Alters the microRNA Expression Profiles of Progenitor Cell Populations

Circulating MicroRNA ( miRNA) Expression Signatures in Type 1 diabetic (T1D) Individuals Protected from Development of Diabetic Retinopathy (DR)

Control of physiological and pathological angiogenesis in the retina by the matricellular protein CCN1

The Matricellular Protein CCN1 is Required for Growth, Maturation and Stabilization of the Retinal Vasculature

To View More...

You must be signed into an individual account to use this feature.